In a recent study, Daubon T et al. showed that TSP-1 expression is higher in high-grade glioma patient samples, compared with low-grade gliomas, and TGFβ1 regulates TSP-1 expression via SMAD3-binding sites. Here, SMAD3 is linked to central nervous system cancer.